| Dr Angela N R Miller, PHD, MPH | |
|
4833 Darrow Rd, Suite 101, Stow, OH 44224-1411 | |
| (330) 650-5338 | |
| (330) 342-3837 |
| Full Name | Dr Angela N R Miller |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 11 Years |
| Location | 4833 Darrow Rd, Stow, Ohio |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558768366 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Vista Psychological And Counseling Centre Llc | 2365517836 | 5 |
News Archive
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the oral presentation of new data on its Smac mimetic drug candidate TL32711 at the 53rd ASH Annual Meeting and Exposition in San Diego.
The U.S. Centers for Disease Control and Prevention (CDC) recently published a new guideline, recognizing that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread via aerosols. Now, the health agency takes back its statement by deleting the updates published on Sept. 18.
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.
Seth Lederman, M.D., President and CEO of New York City-based Tonix Pharmaceuticals Holding Corp. (OTCBB:TNXP) says that a good night's sleep is a potentially powerful, but currently elusive, treatment for the chronic pain and sleep disorders suffered by patients with fibromyalgia (FM), post-traumatic stress disorder (PTSD), traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE).
› Verified 8 days ago
| Entity Name | Vista Psychological & Counseling Centre Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558535658 PECOS PAC ID: 2365517836 Enrollment ID: O20080818000573 |
News Archive
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the oral presentation of new data on its Smac mimetic drug candidate TL32711 at the 53rd ASH Annual Meeting and Exposition in San Diego.
The U.S. Centers for Disease Control and Prevention (CDC) recently published a new guideline, recognizing that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread via aerosols. Now, the health agency takes back its statement by deleting the updates published on Sept. 18.
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.
Seth Lederman, M.D., President and CEO of New York City-based Tonix Pharmaceuticals Holding Corp. (OTCBB:TNXP) says that a good night's sleep is a potentially powerful, but currently elusive, treatment for the chronic pain and sleep disorders suffered by patients with fibromyalgia (FM), post-traumatic stress disorder (PTSD), traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE).
› Verified 8 days ago
| Entity Name | Doctor On Demand Professionals P C |
|---|---|
| Entity Type | Part B Supplier - Other |
| Entity Identifiers | NPI Number: 1174931448 PECOS PAC ID: 9436464567 Enrollment ID: O20200515000675 |
News Archive
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the oral presentation of new data on its Smac mimetic drug candidate TL32711 at the 53rd ASH Annual Meeting and Exposition in San Diego.
The U.S. Centers for Disease Control and Prevention (CDC) recently published a new guideline, recognizing that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread via aerosols. Now, the health agency takes back its statement by deleting the updates published on Sept. 18.
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.
Seth Lederman, M.D., President and CEO of New York City-based Tonix Pharmaceuticals Holding Corp. (OTCBB:TNXP) says that a good night's sleep is a potentially powerful, but currently elusive, treatment for the chronic pain and sleep disorders suffered by patients with fibromyalgia (FM), post-traumatic stress disorder (PTSD), traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Angela N R Miller, PHD, MPH 4833 Darrow Rd, Suite 101, Stow, OH 44224-1411 Ph: (330) 650-5338 | Dr Angela N R Miller, PHD, MPH 4833 Darrow Rd, Suite 101, Stow, OH 44224-1411 Ph: (330) 650-5338 |
News Archive
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule Smac mimetic drugs to treat cancer, today announced the oral presentation of new data on its Smac mimetic drug candidate TL32711 at the 53rd ASH Annual Meeting and Exposition in San Diego.
The U.S. Centers for Disease Control and Prevention (CDC) recently published a new guideline, recognizing that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can spread via aerosols. Now, the health agency takes back its statement by deleting the updates published on Sept. 18.
The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer's disease and affects more than 3 million aging Americans.
Seth Lederman, M.D., President and CEO of New York City-based Tonix Pharmaceuticals Holding Corp. (OTCBB:TNXP) says that a good night's sleep is a potentially powerful, but currently elusive, treatment for the chronic pain and sleep disorders suffered by patients with fibromyalgia (FM), post-traumatic stress disorder (PTSD), traumatic brain injury (TBI) and chronic traumatic encephalopathy (CTE).
› Verified 8 days ago
Lori Marie Wills, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4833 Darrow Rd Ste 100, Stow, OH 44224 Phone: 330-422-3255 Fax: 330-422-3256 | |
Mary E. Hickcox, Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4833 Darrow Rd, Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Richard J Shurell, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4833 Darrow Road Suite 101, Western Reserve Psychological Associates Inc, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Suzanne H Hetrick, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4833 Darrow Road Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Dr. Jay Levine, PH.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 4833 Darrow Rd, Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Carole P Smith, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 4833 Darrow Road Suite 101, Stow, OH 44224 Phone: 330-650-5338 Fax: 330-342-3837 | |
Donna Mcdonald, PHD Psychologist Medicare: Medicare Enrolled Practice Location: 4833 Darrow Rd Ste 101, Stow, OH 44224 Phone: 330-650-5338 |